CONNECT WITH US
HealthTech

HealthTech

Menopause is a biological transition that's become a lucrative consumer business

Medical Xpress logo

Published on

Add as a preferred source on Google
Menopause is a biological transition that's become a lucrative consumer business

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Long relegated to the private sphere, menopause is now the focus of unprecedented attention both in the media and commercially, with a market value of 535 billion euros ($600 billion). The number of books, podcasts, documentaries, digital applications, food supplements and coaching programs is multiplying to support women in this stage of life. What was once a taboo subject has become a booming economic sector.

This evolution constitutes an important step forward: People are talking more about menopause, it is better understood and is gradually being recognized as a public health issue. But this visibility is also accompanied by bold marketing. As the topic enters the public arena, it also becomes a niche market opportunity.

This transformation raises a question at the heart of the analysis in "All Change! Marketing and Consuming the Menopause Transition": Does it genuinely meet women's needs, or does it help create a new market built on their concerns, symptoms and desire for well-being?

The book conceptualizes the emergence of menopause as a consumer market in its own right. This niche market is characterized by growing "climacteric market awareness" and by the gradual transformation of menopause into a space for commercial gain, bodily intervention and self-optimization. (Editor's note: The philosopher Gloria Origgi explains that "climacteric" may derive from the Greek word "klimax," meaning step or rung.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.